| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.684 | 25411331
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.52 | 0.684 | 27694834
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.684 | 34059086
|
| ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.684 | 31100681
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.7582 | 25411331
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | Cisplatin | Western Blotting followed by FACs | NA | 0.52 | 0.7582 | 30754694
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.52 | 0.7582 | 27694834
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 34059086
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 34059086
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 31100681
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and SP assay | NA | 0.52 | 0.7582 | 26911281
|
| PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | RT-PCR | NA | 0.52 | 0.7582 | 32090054
|
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | Western Blotting followed by FACs | NA | 0.4 | 1 | 30754694
|
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.4 | 1 | 27694834
|
| CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.4 | 1 | 34059086
|
| CD24 | 1645 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.32 | 0.456 | 27694834
|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1739 | 31100681
|
| ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and SP assay | NA | 0.28 | 0.1739 | 26911281
|
| NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 34209829
|
| POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 34209829
|
| SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 34209829
|
| A2M | 7 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| AARD | 33842 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ABCA9-AS1 | 39983 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| AKAP8 | 378 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ALKBH6 | 28243 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ANKRD20A12P | 43603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ANKRD52 | 26614 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ANKRD53 | 25691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| AP4B1 | 572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| APTR | 44173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ARHGAP31 | 29216 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ARID1A | 11110 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ARID5A | 17361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| ASAP3 | 14987 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ATAD3C | 32151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ATF7IP | 20092 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ATP2A1 | 811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| AURKA | 11393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| BAHD1 | 29153 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| BAX | 959 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
| BAZ2A | 962 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| BCOR | 20893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| BPESC1 | 13228 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| BRCA1 | 1100 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| BRWD1 | 12760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| BTN3A2 | 1139 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| C16ORF82 | 30755 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| C9ORF85 | 28784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CABIN1 | 24187 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CAT | 1516 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| CBL | 1541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| CCBL1 | 1564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CCDC130 | 28118 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CCDC65 | 29937 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CCL23 | 10622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CDC20 | 1723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| CELA3B | 15945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CEP83 | 17966 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CHAC2 | 32363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| CHAD | 1909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CKMT1A | 31736 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| CLPTM1L | 24308 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CLRN1 | 12605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CNST | 26486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| COLEC10 | 2220 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| COPS7A | 16758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CORO1B | 2253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CPEB1 | 21744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CRYBG2 | 17295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| CRYGS | 2417 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| CYB561 | 2571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| CYP2R1 | 20580 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| CYP4F2 | 2645 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DCAF12 | 19911 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DDB1 | 2717 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| DEFB136 | 34433 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DEXI | 13267 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DGCR5 | 16757 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DLG5 | 2904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| DST | 1090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| DUX4 | 50800 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| DYNC2I1 | 21862 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| EFHC1 | 16406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| EIF2D | 6583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| EIF2D | 6583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| EMC6 | 28430 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| EMC8 | 7864 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ENOPH1 | 24599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| EPHB1 | 3392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ERO1A | 13280 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| ESYT3 | 24295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ETFDH | 3483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| EXOSC6 | 19055 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FAM238B | 44917 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FAM98B | 26773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| FBXO42 | 29249 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FGD5P1 | 44498 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FHAD1 | 29408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FHL2 | 3703 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
| FLJ46363 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| FLOT2 | 3758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| FPGT-TNNI3K | 42952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GCOM1 | 26424 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| GINS2 | 24575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GLRA2 | 4327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GLTPD2 | 33756 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GPALPP1 | 20298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GPR155 | 22951 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GPR157 | 23687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GPR179 | 31371 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GRM7 | 4599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GSPT2 | 4622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| GSTCD | 25806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GTF2H2C_2 | 35418 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| GTPBP1 | 4669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| HAO1 | 4809 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| HORMAD2-AS1 | 50729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| HTR2A | 5293 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| IFI30 | 5398 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| IGFBP2 | 5471 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| ILDR2 | 18131 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| IQCJ-SCHIP1 | 38842 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| JPT1 | 14569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| KBTBD11-OT1 | 49147 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| KBTBD6 | 25340 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| KCP | 17585 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| KIRREL2 | 18816 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| KLB | 15527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| KLHL6-AS1 | 40850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| KRTAP10-10 | 22972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC00240 | 18772 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC00865 | 45170 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC00877 | 27706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC00885 | 48571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| LINC00989 | 48918 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC01016 | 48991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| LINC01121 | 49266 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC01152 | 16752 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC01304 | 50472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC01493 | 51150 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINC01514 | 51207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LINS1 | 30922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| LOC124902802 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| LRATD2 | 24166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| LRIG1 | 17360 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
| LYRM4 | 21365 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MAPK12 | 6874 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MAPK8IP2 | 6883 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MAPKAPK3 | 6888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| ME2 | 6984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| MEF2C | 6996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| MFSD9 | 28158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MGST2 | 7063 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
| MIR940 | 33683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| MLANA | 7124 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MMP25-AS1 | 51372 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MR1 | 4975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MROH1 | 26958 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MTFP1 | 26945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| MTRNR2L2 | 37156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NCRNA00250 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NECAP1 | 24539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NGEF | 7807 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NGRN | 18077 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NIFK-AS1 | 27385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NKD1 | 17045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NOL4L | 16106 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NPPA | 7939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NRG2 | 7998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| NSUN6 | 23529 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| NUMA1 | 8059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| OR10Z1 | 14996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| OR5AK2 | 15251 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PCLAF | 28961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| PEPD | 8840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| PGD | 8891 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
| PILRA | 20396 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PLOD1 | 9081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| PLPPR4 | 23496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PNCK | 13415 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PNPLA2 | 30802 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| POLA2 | 30073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| POLD2 | 9176 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PPIL4 | 15702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PPP1R21 | 30595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PPP1R26 | 29089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PQLC2 | 26001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PSME4 | 20635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PSMF1 | 9571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| PVRIG | 32190 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RAB39A | 16521 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RAB9B | 14090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RAC1 | 9801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| RAD21L1 | 16271 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RASD1 | 15828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| RBBP4 | 9887 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RBPMS | 19097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| REV1 | 14060 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RFC5 | 9973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| RLIM | 13429 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RNF186 | 25978 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RNU6ATAC | 34017 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RPL21 | 10313 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RPL3 | 10332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| RPL37A | 10348 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| RPL7 | 10363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| RPRD1B | 16209 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RSBN1L | 24765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| RTN4IP1 | 18647 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| RXRG | 10479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SCGB3A1 | 18384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SELENOV | 30399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SH2D5 | 28819 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SHISA7 | 35409 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SIRPG-AS1 | 51229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SLC25A6 | 10992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| SLC2A9 | 13446 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SLC33A1 | 95 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SLC47A1 | 25588 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| SLC4A2 | 11028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SLC5A11 | 23091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SMAD5 | 6771 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SMAD9 | 6774 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SNAP25-AS1 | 44312 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SNORA78 | 32664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SNORD5 | 32702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SPIDR | 28971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SPTLC1 | 11277 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SREK1IP1 | 26716 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| SRP9 | 11304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| STXBP5-AS1 | 44183 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| STYXL1 | 18165 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SUGP2 | 18641 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SX2 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| SYNJ2BP-COX16 | 48350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TDRD7 | 30831 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TEKT4P2 | 40046 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TEX13B | 11736 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TGFB1 | 11766 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0138 | 34059086
|
| TMEM176B | 29596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TNFSF9 | 11939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| TNXB | 11976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TRIM66 | 29005 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TSHR | 12373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TSPYL1 | 12382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TTC9B | 26395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| TUBGCP6 | 18127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| UNC13C | 23149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| UNC5B | 12568 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| USP11 | 12609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| USP12-AS1 | 39961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| VAC14-AS1 | 48605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| VAMP4 | 12645 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| VCPIP1 | 30897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| VTI1A | 17792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| VWA8 | 29071 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| WASF1 | 12732 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
| WNK2 | 14542 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| XAB2 | 14089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| XKR6 | 27806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| XPO7 | 14108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| YWHAH | 12853 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ZBTB21 | 13083 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZC3HAV1 | 23721 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZFP36L2 | 1108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZFTA | 28449 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZFYVE28 | 29334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZNF468 | 33105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
| ZNF496 | 23713 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZNF555 | 28382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZNF586 | 25949 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
| ZZEF1 | 29027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|